# A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088

> **NCT06579300** · PHASE1 · TERMINATED · sponsor: **AbbVie** · enrollment: 72 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** ABBV-1088
- **DRUG:** Placebo for ABBV-1088
- **DRUG:** Itraconazole (ITZ)

## Key facts

- **NCT ID:** NCT06579300
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-09-04
- **Primary completion:** 2025-09-03
- **Final completion:** 2025-09-03
- **Target enrollment:** 72 (ACTUAL)
- **Why stopped:** Strategic considerations
- **Last updated:** 2025-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06579300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06579300, "A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06579300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*